Good read
Merck Sales Beat Estimates, But the Stock Is Falling. Here’s 1 Reason to Be Bullish.
Merck’s second-quarter sales outpaced Wall Street expectations while earnings per share came in line
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
5
举报
登录后可参与评论

暂无评论
Good read
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。